Viewing Study NCT03663166


Ignite Creation Date: 2025-12-24 @ 4:07 PM
Ignite Modification Date: 2026-02-20 @ 1:11 AM
Study NCT ID: NCT03663166
Status: TERMINATED
Last Update Posted: 2023-02-15
First Post: 2018-09-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-11-20
Start Date Type: ACTUAL
Primary Completion Date: 2021-10-22
Primary Completion Date Type: ACTUAL
Completion Date: 2021-10-22
Completion Date Type: ACTUAL
First Submit Date: 2018-09-06
First Submit QC Date: None
Study First Post Date: 2018-09-10
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-10-21
Results First Submit QC Date: None
Results First Post Date: 2023-02-15
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-02-14
Last Update Post Date: 2023-02-15
Last Update Post Date Type: ACTUAL